|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q87834060
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010735.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q87834060
|
|
024
|
|
|
‡a
0000-0002-5181-4456
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q87834060
|
|
100
|
0 |
|
‡a
Massimo Dal Monte
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Massimo Dal Monte
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's 3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells
|
|
670
|
|
|
‡a
Author's A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
|
|
670
|
|
|
‡a
Author's Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System.
|
|
670
|
|
|
‡a
Author's Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration
|
|
670
|
|
|
‡a
Author's Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis.
|
|
670
|
|
|
‡a
Author's Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis
|
|
670
|
|
|
‡a
Author's Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy.
|
|
670
|
|
|
‡a
Author's Lisosan G Protects the Retina from Neurovascular Damage in Experimental Diabetic Retinopathy
|
|
670
|
|
|
‡a
Author's Neuroprotection as a Therapeutic Target for Diabetic Retinopathy
|
|
670
|
|
|
‡a
Author's Novel Insights into Beta 2 Adrenergic Receptor Function in the rd10 Model of Retinitis Pigmentosa
|
|
670
|
|
|
‡a
Author's Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy
|
|
670
|
|
|
‡a
Author's Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen-induced retinopathy: beneficial effect of the absence of AQP4.
|
|
670
|
|
|
‡a
Author's Protective Efficacy of a Dietary Supplement Based on Forskolin, Homotaurine, Spearmint Extract, and Group B Vitamins in a Mouse Model of Optic Nerve Injury
|
|
670
|
|
|
‡a
Author's The uPAR System as a Potential Therapeutic Target in the Diseased Eye
|
|
670
|
|
|
‡a
Author's The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model
|
|
670
|
|
|
‡a
Author's β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β3 -adrenoceptors
|
|
670
|
|
|
‡a
Author's β3 -Adrenoceptor as a potential immuno-suppressor agent in melanoma
|
|
909
|
|
|
‡a
(orcid) 0000000251814456
‡9
1
|
|
919
|
|
|
‡a
3adrenoreceptorscontrolmitochondrialdormancyinmelanomaandembryonicstemcells
‡A
3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells
‡9
1
|
|
919
|
|
|
‡a
topicalformulationofmelatoninergiccompoundsexertsstronghypotensiveandneuroprotectiveeffectsinaratmodelofhypertensiveglaucoma
‡A
A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
‡9
1
|
|
919
|
|
|
‡a
diabeticretinopathyinthespontaneouslydiabetictoriiratpathogeneticmechanismsandpreventiveefficacyofinhibitingtheurokinasetypeplasminogenactivatorreceptorsystem
‡A
Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System.
‡9
1
|
|
919
|
|
|
‡a
efficacyofafattyacidsdietarysupplementinapolyethyleneglycolinducedmousemodelofretinaldegeneration
‡A
Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration
‡9
1
|
|
919
|
|
|
‡a
fattyacidsdietarysupplementsexertantiinflammatoryactionandlimitganglioncelldegenerationintheretinaoftheeaemousemodelofmultiplesclerosis
‡A
Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis.
‡9
1
|
|
919
|
|
|
‡a
furtherevidenceonefficacyofdietsupplementationwithfattyacidsinocularpathologiesinsightsfromtheeaemodelofopticneuritis
‡A
Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis
‡9
1
|
|
919
|
|
|
‡a
inhibitingtheurokinasetypeplasminogenactivatorreceptorsystemrecoversstzinduceddiabeticnephropathy
‡A
Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy.
‡9
1
|
|
919
|
|
|
‡a
lisosangprotectstheretinafromneurovasculardamageinexperimentaldiabeticretinopathy
‡A
Lisosan G Protects the Retina from Neurovascular Damage in Experimental Diabetic Retinopathy
‡9
1
|
|
919
|
|
|
‡a
neuroprotectionasatherapeutictargetfordiabeticretinopathy
‡A
Neuroprotection as a Therapeutic Target for Diabetic Retinopathy
‡9
1
|
|
919
|
|
|
‡a
novelinsightsintobeta2adrenergicreceptorfunctionintherd10modelofretinitispigmentosa
‡A
Novel Insights into Beta 2 Adrenergic Receptor Function in the rd10 Model of Retinitis Pigmentosa
‡9
1
|
|
919
|
|
|
‡a
oxidativestressinducesavegfautocrineloopintheretinarelevancefordiabeticretinopathy
‡A
Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy
‡9
1
|
|
919
|
|
|
‡a
potentialroleofthemethylationofvegfgenepromoterinresponsetohypoxiainoxygeninducedretinopathybeneficialeffectoftheabsenceofaqp4
‡A
Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen-induced retinopathy: beneficial effect of the absence of AQP4.
‡9
1
|
|
919
|
|
|
‡a
protectiveefficacyofadietarysupplementbasedonforskolinhomotaurinespearmintextractandgroupbvitaminsinamousemodelofopticnerveinjury
‡A
Protective Efficacy of a Dietary Supplement Based on Forskolin, Homotaurine, Spearmint Extract, and Group B Vitamins in a Mouse Model of Optic Nerve Injury
‡9
1
|
|
919
|
|
|
‡a
uparsystemasapotentialtherapeutictargetinthediseasedeye
‡A
The uPAR System as a Potential Therapeutic Target in the Diseased Eye
‡9
1
|
|
919
|
|
|
‡a
urokinasetypeplasminogenactivatorsystemasdrugtargetinretinitispigmentosanewpreclinicalevidenceintherd10mousemodel
‡A
The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model
‡9
1
|
|
919
|
|
|
‡a
βadrenoceptorsasdrugtargetsinmelanomanovelpreclinicalevidenceforaroleofβ3adrenoceptors
‡A
β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β3 -adrenoceptors
‡9
1
|
|
919
|
|
|
‡a
β3adrenoceptorasapotentialimmunosuppressoragentinmelanoma
‡A
β3 -Adrenoceptor as a potential immuno-suppressor agent in melanoma
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000489023339
|
|
996
|
|
|
‡2
BLBNB|001435547
|
|
996
|
|
|
‡2
BNF|13531391
|
|
996
|
|
|
‡2
BIBSYS|90085516
|
|
996
|
|
|
‡2
PTBNP|163057
|
|
996
|
|
|
‡2
SUDOC|145665135
|
|
996
|
|
|
‡2
ISNI|0000000070990231
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
